Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters
Open Access
- 30 October 2019
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 287 (7) , 1306-1322
Abstract
Detoxication, or ‘drug‐metabolizing’, enzymes and drug transporters exhibit remarkable substrate promiscuity and catalytic promiscuity. In contrast to substrate‐specific enzymes that participate in defined metabolic pathways, individual detoxication enzymes must cope with substrates of vast structural diversity, including previously unencountered environmental toxins. Presumably, evolution selects for a balance of ‘adequate’ kcat/KM values for a wide range of substrates, rather than optimizing kcat/KM for any individual substrate. However, the structural, energetic, and metabolic properties that achieve this balance, and hence optimize detoxication, are not well understood. Two features of detoxication enzymes that are frequently cited as contributions to promiscuity include the exploitation of highly reactive versatile cofactors, or cosubstrates, and a high degree of flexibility within the protein structure. This review examines these intuitive mechanisms in detail and clarifies the contributions of the classic ligand binding models ‘induced fit’ (IF) and ‘conformational selection’ (CS) to substrate promiscuity. The available literature data for drug metabolizing enzymes and transporters suggest that IF is exploited by these promiscuous detoxication enzymes, as it is with substrate‐specific enzymes, but the detoxication enzymes uniquely exploit ‘IFs’ to retain a wide range of substrates at their active sites. In contrast, whereas CS provides no catalytic advantage to substrate‐specific enzymes, promiscuous enzymes may uniquely exploit it to recruit a wide range of substrates. The combination of CS and IF, for recruitment and retention of substrates, can potentially optimize the promiscuity of drug metabolizing enzymes and drug transporters.Keywords
Funding Information
- Center for Scientific Review (R01GM121603, R01GM130810)
This publication has 102 references indexed in Scilit:
- Structural and Mechanistic Insights into the Interaction of Cytochrome P4503A4 with Bromoergocryptine, a Type I LigandJournal of Biological Chemistry, 2012
- Ensemble Perspective for Catalytic PromiscuityJournal of Biological Chemistry, 2011
- Catalytic versus Inhibitory Promiscuity in Cytochrome P450s: Implications for Evolution of New FunctionBiochemistry, 2011
- Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation KineticsScience, 2010
- Substrate Specificity Combined with Stereopromiscuity in Glutathione Transferase A4-4-Dependent Metabolism of 4-HydroxynonenalBiochemistry, 2010
- Structural Analysis of a Glutathione Transferase A1-1 Mutant Tailored for High Catalytic Efficiency with Toxic AlkenalsBiochemistry, 2009
- Role of Induced Fit in Enzyme Specificity: A Molecular Forward/Reverse SwitchJournal of Biological Chemistry, 2008
- Regioselectivity of human UDP-glucuronosyl-transferase 1A1 in the synthesis of flavonoid glucuronides determined by metal complexation and tandem mass spectrometryJournal of the American Society for Mass Spectrometry, 2008
- Structural basis for ligand promiscuity in cytochrome P450 3A4Proceedings of the National Academy of Sciences, 2006
- Functionally diverging molecular quasi-species evolve by crossing two enzymesProceedings of the National Academy of Sciences, 2006